Skip to main content

Table 3 Levels of significance (P) of the differences between corresponding values in samples grown with and without AZA.

From: The aberrant asynchronous replication — characterizing lymphocytes of cancer patients — is erased following stem cell transplantation

 

TP53

CEN17

AML1

SNRPN

Chromosome 17

Chromosome 21

CON

(n = 20)

P > 0.20

P > 0.10

P > 0.05

P > 0.70

P > 0.60

P > 0.50

ADI

(n = 20)

P < 10-13

P < 10-12

P < 10-15

P > 0.50

P > 0.30

P > 0.20

PRE

(n = 14)

P < 10-11

P < 10-9

P < 10-6

-----

P > 0.10

P > 0.40

  1. CON - samples of cancer free subjects; ADI - samples of patients with hematological malignancies obtained at diagnosis; PRE - samples of patients with hematological malignancies taken prior to alloSCT; AZA - 5-azacytidine; n - Number of cases tested within each group for each locus/chromosome; SD values - columns 1-4; and aneuploidy levels - columns 4 and 5.